Summary of top read business stories July 26 to 31


However, Malaysia University of Science and Technology or MUST professor Dr Geoffrey Williams believes Malaysia will see a long-haul recovery.

Top read stories include AstraZenecca, Pos Malaysia, AIA Malaysia and TNG Digital, Silterra, National Recovery Plan, food delivery platforms

AstraZeneca's Covid-19 shot did not increase the instances of rare blood clots with low platelets in people after the second dose, a study showed on Wednesday, potentially easing some worries over the vaccine's side-effects.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Business News

China says tax breaks to stay for over 90% of new energy vehicles
Oil extends gains on US strategic reserve purchases
Asian currencies, equities fall ahead of key cenbank meetings
CIMB Islamic wins Islamic Retail Bank of the Year by The Banker
Manufacturing sales down 1.4% YoY to RM156.7bil in October 2023
Asian stocks slip, rate cut hopes face pivotal week
IPI rebounds 2.7% in October 2023 on robust performance in mining sector
MARC Ratings affirms Malaysia's sovereign rating at AAA
Market to continue range-bound trading
TikTok to buy GoTo's Indonesia e-commerce business in US$1.5bil deal

Others Also Read